Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, today announced the promotion of Rob Harkness, PhD, to the position of Chief Technology Officer. Dr. Harkness previously served as the company’s managing director for the European Union and United Kingdom.

“In the three years Rob has been at Biosero, he has consistently impressed me with his technical competencies, future vision, and commitment to ensuring customer success,” said Tom Gilman, President and CEO at Biosero. “Rob has an extensive background in laboratory automation and a keen sense of what customers need to accelerate their science. I can’t imagine a better fit to be our next CTO as Biosero continues to push the boundaries of what’s possible in lab automation and orchestration.”

Dr. Harkness has more than 20 years of experience in delivering laboratory automation solutions. He joined Biosero in 2020, initially as director of customer success for the EU and UK, working with customers and partners to help them achieve their scientific goals. He has also been instrumental in the development of the company’s business strategy and technology roadmap.

Prior to Biosero, Dr. Harkness held roles of increasing responsibility at automation and robotics companies such as CyBio, Astech Projects, and Peak Analysis and Automation. Dr. Harkness also serves as a director for the Standards in Laboratory Automation (SiLA) consortium, an initiative in the life science community to create open system communication and data standards to promote the utility and accessibility of lab automation. He earned his bachelor of science in computer-aided chemistry and his PhD in biochemical assay automation software, both from the University of Surrey.

“Biosero’s commitment to customers — measuring our success not by installations or units sold but by the automation-powered achievements of the researchers we serve — has resonated with me since day one,” said Dr. Harkness. “I am honored to take on this new role and look forward to guiding Biosero’s technology strategy as we seek to empower customers and laboratories around the world with our software and automation solutions.”

Biosero’s outgoing CTO, David Dambman, will continue to consult with the company on automation and technology projects. “I am deeply grateful to David for giving so much of himself to Biosero and our customers for the past 13 years,” said Mr. Gilman. “He transformed both our and the industry’s overall approach to laboratory automation with his development of Green Button Go software and I’m thrilled that we will have the opportunity to continue working together even as he moves to his next chapter.”

About Biosero, Inc.

Biosero, a member of the BICO group, develops science-centric software and laboratory automation solutions that enable researchers to orchestrate their discoveries at every stage. Biosero’s Green Button Go^® Scheduler software and integration services match laboratory automation to science, creating a cohesive technology ecosystem that accelerates operations and increases productivity. Additionally, Green Button Go Orchestrator applications provide an end-to-end laboratory management solution, directing workflows and operations in life science, biotechnology, pharmaceutical, and diagnostic research. Biosero is passionate about partnering with organizations dedicated to enhancing life by addressing the world’s most significant needs. For more information, please visit www.biosero.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230801584023/en/